Printer Friendly Copy

ehabilitative Management of Patients with Parkinson's Disease and other Neurodegenerative Diseases

Education Resources, Inc.

Objectives

At the end of the course, attendees will be able to:
Summarize fundamentals of pathology associated with PD, secondary parkinsonisms, typicalparkinonisms, MS, ALS, and HD
Identify clinical signs and symptoms of PD and parkinsonisms, MS, ALS, and HD
a. Describe motor and non-motor signs of PD and parkinsonisms
b. Summarize various cognitive impairments and their impact on functional mobility
Summarize the mechanism of action, clinical candidacy, and common side effects of disease-specific medications of PD, MS, ALS, and HD
Identify appropriate outcome measures related to disease-specific impairments of PD, MS, ALS, and HD
Apply research-based interventions for PD, MS, ALS, and HD
Describe long-term management of patients with PD, MS, ALS, and HD through all therapy services and community-based programs

Confirmation Notes

This course meets the criteria for 13 contact hours (1.3 CEUs.)
Application has been made to the MD and NJ Board of Physical Therapy Examiners. The DC, DE, PA and VA Boards of Physical Therapy accept other board's approval.
Approved provider by the NY State Board of Physical Therapy for 15.6 contact hours
Approved provider of continuing education by the American Occupational Therapy Association #3043, for 13 contact hours - Intermediate Level Occupational Therapy Process: assessment, intervention. The assignment of AOTA CEU's does not imply endorsement of specific course content, products or clinical procedures by AOTA.
NBCOT Professional Development Provider - 13 PDUs
This course is offered for up to 1.3 ASHA CEUs (Intermediate level, Professional area).

Agenda

Schedule – Day 1
7:30-8:00 Registration/Continental Breakfast 8:00-8:30 Pathology of PARKINSON’S DISEASE 8:30-9:15 Clinical Presentation and Diagnosis •Motor Signs, Non-Motor Signs, Diagnosis (*MDS Criteria, Imaging, Genetic Markers) 9:15-9:30 Break 9:30-10:45 Pharmacology and Medical Management •Dopaminergic therapies: mechanism of action, drug classes, etc. •Common secondary medications •Deep Brain Stimulation •Complementary Alternative Medicine •Current clinical trials (STEADY-PD, SURE- PD, NILO-PD, PASSPORT) 10:45-11:30 Selecting Outcomes and Writing Goals 11:30-12:30 Lunch (on your own) 12:30-2:30 Evidence-Based Practice Guidelines •Bradykinetic gait, instability, and freezing of gait (FOG) •Strength training principles •Tai Chi, yoga, and mindfulness •Volume control and swallowing •Fine motor control •Parkinson’s-specific Large Amplitude Training i.e. LSVT BIG, PWR!Moves, SPEAKOut! •Community Programs & Support Group Information for Patient Dissemination 2:30-2:45 Break 2:45-4:00 Secondary and Atypical Parkinsonism •Secondary Parkinsonisms (NPH, Drug Induced, Vascular, Metabolic, Brain Inj/CTE •Clinical Presentation, Diagnosis, and Treatment •Pathology, clinical presentation, diagnosis and treatment of Atypical Parkinsonisms: PSP, CBD, and MSA (Prime of Life Diseases)

Schedule – Day 2
7:30-8:00 Continental Breakfast 8:00-9:00 MULTIPLE SCLEROSIS: Diagnosis Presentation, and Medical Management •Motor/Non-motor signs, Disease scales Diagnostic criteria, DMTs and Secondary medications 9:00-9:15 Selecting Outcomes and Writing Goals 9:15-10:15 Evidence-based treatment principles •Techniques for managing fatigue •Cognitive strategies •Balance and falls prevention •Gait and strength training parameters •Complementary Alternative Medicine •Patient resources (i.e. National MS Society, MS Society of America – (cooling vests) 10:15-10:30 Break 10:30-11:00 AMYOTROPHIC LATERAL SCLEROSIS Diagnosis, Presentation, and Medical Management •UMN vs LMN signs •Disease scales and diagnostic criteria •Disease modifying therapies / recent research & updates •Secondary medications 11:00-11:15 Selecting Outcomes and Writing Goals 11:15-12:00 Evidence-based treatment principles •Energy conservation •Strength and mobility training •Speech and swallowing 12:00-1:00 Lunch (on your own) 1:00-1:30 HUNTINGTON’S DISEASE Diagnosis, Presentation, and Medical Management •Motor signs •Non-motor signs •Emotional/Behavioral signs •Diagnostic criteria •Symptom management 1:30-1:45 Selecting Outcomes and Writing Goals 1:45-2:30 Evidence-based treatment principles •Behavioral therapies and considerations, Strength training, mobility, and postural interventions, Balance and falls prevention, Environmental changes for success 2:30-2:45 Break 2:45-4:00 Wheelchair Prescription & Assistive Technology in Neurodegenerative Disease

Description

How do you define success in treatment of a progressive condition? Neurodegenerative conditions such as Parkinson’s disease, multiple sclerosis, amyotrophic lateral sclerosis, and Huntington’s disease present individuals with new, often worsening, impairments as the conditions progress. While it may come off as a daunting task, rehabilitation professionals play a crucial role in addressing the ‘now’ and preparing for the ‘what if.’
Specific motor impairments, such as freezing of gait in Parkinson’s disease or spasticity in multiple sclerosis, provide unique challenges to mobility and daily activities. Not only are there physical signs we must address in therapy services, but also the non-motor impairments. Oftentimes decreased attention, difficulty multitasking, and behavioral barriers limit our ability to maintain or improve a patient’s functional status.
This course aims to improve clinician skills from diagnosis through late-stage disease management. Literature review, video case studies, and group discussions will be useful in building your skills. Improved understanding of diagnoses, pathologies, and medical management is necessary when considering the clinical decision-making process. This information leads us to define appropriate goals, apply evidence-based interventions, and care for all of the complexities that come along with an uphill battle against neurodegeneration.

Date And Locations
Provider does not currently list available courses on RehabEdge.